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Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration
Guodong Lia,b, Grace L. Guoc
aDepartment of General Surgery, the Fourth Hospital of Harbin Medical University, Harbin 150001, China
bDivision of Biobank Research, Department of General Surgery, the Fourth Hospital of Harbin
Medical University, Harbin 150001, China
cDepartment of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers,
the State University of New Jersey, Piscataway, NJ 08854, USAThis review focuses on the roles of bile acids (BAs) and farnesoid X receptor (FXR) in liver regeneration and
the current underlying molecular mechanisms which contribute to liver regeneration.
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The human gut sterolbiome: bile acid–microbiome endocrine aspects and therapeutics
Jason M. Ridlona,b, Jasmohan S. Bajajb,c
aDepartment of Microbiology and Immunology, Virginia Commonwealth University,
Richmond, VA 23298, USA
bMcGuire VA Medical Center, Richmond, VA 23249, USA
cDivision of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University,
Richmond, VA 23298, USAWe propose the term “sterolbiome” to describe the genetic potential of the gut microbiome to produce
endocrine molecules from endogenous and exogenous steroids in the mammalian gut. The afﬁnity of
secondary bile acid metabolites to host nuclear receptors is described; the potential of secondary bile acids
to promote tumors, and the potential of bile acids to serve as therapeutic agents are discussed.
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Epigenetic regulation of drug metabolism and transport
Lai Penga,b, Xiao-bo Zhonga
aDepartment of Pharmaceutical Sciences, School of Pharmacy, University of
Connecticut, Storrs, CT 06269, USA
bKey Laboratory of System Biomedicine, Center for Comparative Biomedicine,
Institute of Systems Biomedicine, Shanghai Jiao Tong University, Shanghai 200240, ChinaThis review examines the widespread effect of epigenetic regulations on genes involved in drug
metabolism, and also suggests a network perspective of epigenetic regulation.
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Circadian rhythms in liver metabolism and disease
Jessica M. Ferrell, John Y.L. Chiang
Department of Integrative Medical Sciences, Northeast Ohio Medical University,
Rootstown, OH 44272, USAShift work, chronic jet lag and sleep disturbances are associated with increased incidence of metabolic syndrome,
and consequently result in obesity, type 2 diabetes and dyslipidemia. Here, these associations are reviewed with
respect to liver metabolism and disease.
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Bile acid signaling and biliary functionsHannah Jonesb, Gianfranco Alpinia,b,c, Heather Francisa,b,c
aDivision Research, Central Texas Veterans Health Care System, Temple, TX 76504, USA
bBaylor Scott & White Digestive Disease Research Center, Temple, TX 76504, USA
cDepartment of Medicine, Texas A&M University, Temple, TX 76504, USAThis review focuses on various components of bile acid signaling in relation to cholangiocytes.
Their roles as targets for potential therapies for cholangiopathies are also explored. While many factors are
involved in these complex signaling pathways, this review emphasizes the roles of transmembrane G protein
coupled receptor (TGR5), farnesoid X receptor (FXR), ursodeoxycholic acid (UDCA) and the
bicarbonate umbrella.
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Metabolic effects of intestinal absorption and enterohepatic cycling of bile acidsCourtney B. Ferrebeea,b, Paul A. Dawsona
aDepartment of Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition,
Emory University, Atlanta, GA 30322, USA
bMolecular Medicine Graduate Program, Wake Forest School of Medicine,
Winston-Salem, NC 27153, USAThis review discusses recent advances in our understanding of the inter-relationship between the
enterohepatic cycling of bile acids and the metabolic consequences of signaling via bile acid-activated
receptors such as farnesoid X nuclear receptor (FXR) and the G-protein-coupled bile acid receptor (TGR5).
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Bile acid nuclear receptor FXR and digestive system diseasesLili Dinga,b, Li Yanga, Zhengtao Wanga, Wendong Huangb
aShanghai Key Laboratory of Complex Prescriptions and MOE Key Laboratory for
Standardization of Chinese Medicines, Institute of Chinese Materia Medica,
Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
bDepartment of Diabetes and Metabolic Diseases Research, Beckman
Research Institute, City of Hope National Medical Center, Duarte, CA 91010, USAThe bile-acid-activated nuclear receptor, farnesoid X receptor (FXR), is involved in the
pathophysiology of a wide range of diseases of gastrointestinal tract, including inﬂammatory
bowel disease, colorectal cancer and type 2 diabetes. In this review, authors discuss current
knowledge of the roles of FXR in physiology of the digestive system and the related diseases.
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Emerging role of microRNAs in lipid metabolism
Zhihong Yanga,b, Tyler Cappelloa, Li Wanga,b,c
aDepartment of Physiology and Neurobiology, and the Institute for Systems Genomics,
University of Connecticut, Storrs, CT 06269, USA
bVeterans Affairs Connecticut Healthcare System, West Haven, CT 06516, USA
cDepartment of Internal Medicine, Section of Digestive Diseases, Yale University,
New Haven, CT 06520, USAThis review introduced epigenetic and transcriptional regulation of miRNAs expression. It emphasized
on several representative miRNAs that are functionally involved into lipid metabolism, including
miR-33/33n, miR122, miR27a/b, miR378/378n, miR-34a and miR-21. Understanding the function of
miRNAs in lipid homeostasis may provide potential therapeutic strategies for fatty liver disease.Acta Pharmaceutica Sinica B, 5 (2015) 151
Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism
Eric Kwonga, Yunzhou Lib, Phillip B. Hylemona,b, Huiping Zhoua,b
aDepartment of Microbiology and Immunology, Virginia Commonwealth University,
Medical College of Virginia Campus, Richmond, VA 23298, USA
bMcGuire VA Medical Center, Richmond, VA 23249, USAThis review focuses on recent ﬁndings related to the role of bile acids/S1PR2-mediated
signaling pathways in regulating hepatic lipid metabolism.
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Role of farnesoid X receptor and bile acids in alcoholic liver disease
Sharon Manley, Wenxing Ding
Department of Pharmacology, Toxicology and Therapeutics, the University
of Kansas Medical Center, Kansas City, KS 66160, USAThis review discusses the effects of alcohol consumption on farnesoid X receptor (FXR), bile
acids and gut microbiome as well as their impacts on alcoholic liver disease. Moreover, we summarize
the ﬁndings on FXR, forkhead box-containing protein class O3a and peroxisome proliferator-activated
receptor alpha in regulation of autophagy-related gene transcription program and liver injury
in response to alcohol exposure.
